Results 71 to 80 of about 11,207 (204)
Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia
Rituximab-induced lung disease (R-ILD) is a rare entity that should be considered in patients treated with rituximab who present with dyspnea, fever, and cough, but no clear evidence of infection.
Ahmet B. Ergin, Nancy Fong, Hamed A. Daw
doaj +1 more source
Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia
Introduction. Bortezomib is a proteasome inhibitor indicated for the treatment of multiple myeloma patients. The most frequent side effects are gastrointestinal and neurological. Serious pulmonary complications have been described rarely.
E. Vandeix+5 more
doaj +1 more source
Bronchiolitis Obliterans Organizing Pneumonia in Common Variable Immunodeficiency Syndrome [PDF]
Jack Kaufman, Richard Komorowski
openalex +1 more source
Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation [PDF]
Timothy J. Kroshus+5 more
openalex +1 more source
B7-1, B7-2 and class II MHC molecules in idiopathic pulmonary fibrosis and bronchiolitis obliterans-organizing pneumonia [PDF]
Y. Kaneko+5 more
openalex +2 more sources
Bronchiolitis Obliterans Organizing Pneumonia Associated with AcuteMycoplasma pneumoniaeInfection [PDF]
Josep M. Llibre+4 more
openalex +1 more source
Bronchiolitis obliterans with organising pneumonia: outcome. [PDF]
Ulrich Costabel+2 more
openalex +1 more source
Objective(s): Decrease of quality of life and undesirable sleep quality in individual with bronchiolitis due to chemical exposure reported in previous studies.
Sudabeh Mahdizadeh+6 more
doaj
Swyer-James-Macleod Syndrome presentating as pneumothorax
Swyer-James-MacLeod Syndrome is a rare form of post-infectious bronchiolitis obliterans, characterized by unilateral lung hyperlucency due to loss of pulmonary vasculature and alveolar hyperdistention, in the absence of main bronchial obstruction.
Morgado Mariana+4 more
doaj